Synopsis
0
JDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Topical
Solubilizers
Thickeners and Stabilizers
Controlled & Modified Release
Parenteral
Film Formers & Plasticizers
Direct Compression
Taste Masking
Disintegrants & Superdisintegrants
Co-Processed Excipients
Chewable & Orodispersible Aids
Coating Systems & Additives
Granulation
Emulsifying Agents
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
91
PharmaCompass offers a list of Flunixin Meglumine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flunixin Meglumine manufacturer or Flunixin Meglumine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flunixin Meglumine manufacturer or Flunixin Meglumine supplier.
PharmaCompass also assists you with knowing the Flunixin Meglumine API Price utilized in the formulation of products. Flunixin Meglumine API Price is not always fixed or binding as the Flunixin Meglumine Price is obtained through a variety of data sources. The Flunixin Meglumine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Finadyne manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Finadyne, including repackagers and relabelers. The FDA regulates Finadyne manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Finadyne API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Finadyne manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Finadyne supplier is an individual or a company that provides Finadyne active pharmaceutical ingredient (API) or Finadyne finished formulations upon request. The Finadyne suppliers may include Finadyne API manufacturers, exporters, distributors and traders.
click here to find a list of Finadyne suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Finadyne DMF (Drug Master File) is a document detailing the whole manufacturing process of Finadyne active pharmaceutical ingredient (API) in detail. Different forms of Finadyne DMFs exist exist since differing nations have different regulations, such as Finadyne USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Finadyne DMF submitted to regulatory agencies in the US is known as a USDMF. Finadyne USDMF includes data on Finadyne's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Finadyne USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Finadyne suppliers with USDMF on PharmaCompass.
A Finadyne CEP of the European Pharmacopoeia monograph is often referred to as a Finadyne Certificate of Suitability (COS). The purpose of a Finadyne CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Finadyne EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Finadyne to their clients by showing that a Finadyne CEP has been issued for it. The manufacturer submits a Finadyne CEP (COS) as part of the market authorization procedure, and it takes on the role of a Finadyne CEP holder for the record. Additionally, the data presented in the Finadyne CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Finadyne DMF.
A Finadyne CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Finadyne CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Finadyne suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Finadyne as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Finadyne API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Finadyne as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Finadyne and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Finadyne NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Finadyne suppliers with NDC on PharmaCompass.
Finadyne Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Finadyne GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Finadyne GMP manufacturer or Finadyne GMP API supplier for your needs.
A Finadyne CoA (Certificate of Analysis) is a formal document that attests to Finadyne's compliance with Finadyne specifications and serves as a tool for batch-level quality control.
Finadyne CoA mostly includes findings from lab analyses of a specific batch. For each Finadyne CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Finadyne may be tested according to a variety of international standards, such as European Pharmacopoeia (Finadyne EP), Finadyne JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Finadyne USP).
